Is PTHS up or down today?
PTHS is down 8.37% today, last at 9.30. This stock moved -8.37% versus the prior close.
PTHS · PTHS
PTHS (PTHS) is trading at 9.30, down 8.37% on the session. PTHS sits at the 1% mark of its 52-week range, carries a 14-day RSI of 27, and trades below its 50-day average. Over the past month it is down 56.70%.
Leading the coverage: “Up to $300M in milestone payments are part of Pelthos (PTHS)'s planned merger. - Stock Titan” (Google News Company, 6d ago). PTHS is -43.77% since story.
PTHS trades on a trailing P/E of 26.9 and is running 51.00% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
PTHS is down 8.37% today, last at 9.30. This stock moved -8.37% versus the prior close.
Leading the coverage: “Up to $300M in milestone payments are part of Pelthos (PTHS)'s planned merger. - Stock Titan” (Google News Company, 6d ago). PTHS is -43.77% since story. Dominant story: Pelthos Therapeutics Announces Second Quarter 2026 Financial Results (4 sources, neutral) RSI is 27 — oversold (beaten down) Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026
Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026 - Yahoo Finance Singapore
Form 13D/A Pelthos Therapeutics Inc. For: 3 November By Investing.com - Investing.com India
Pelthos (PTHS) Surges +22.55%, Nearing $12.10 Resistance 2026-11-02 - Ichimoku TK Cross - www.dars.gov.et
Pelthos and Castle Creek plan merger to target skin diseases